A Long-Term Safety Study of OZURDEX® in Clinical Practice

CompletedOBSERVATIONAL

Enrollment

875

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Retinal Vein OcclusionMacular EdemaUveitis, Posterior

Interventions

DRUG

dexamethasone 700 μg intravitreal implant

dexamethasone 700 μg intravitreal implant administered according to general clinical practice.

Trial Locations (4)

Paris

Ulm

Barcelona

Bradford